GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck & Co Inc (NYSE:MRK) » Definitions » E10

Merck (MRK) E10 : $3.80 (As of Mar. 2025)


View and export this data going back to 1949. Start your Free Trial

What is Merck E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Merck's adjusted earnings per share data for the three months ended in Mar. 2025 was $2.010. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $3.80 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Merck's average E10 Growth Rate was 7.30% per year. During the past 3 years, the average E10 Growth Rate was 6.90% per year. During the past 5 years, the average E10 Growth Rate was 10.50% per year. During the past 10 years, the average E10 Growth Rate was 4.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Merck was 15.80% per year. The lowest was -6.40% per year. And the median was 2.60% per year.

As of today (2025-07-07), Merck's current stock price is $80.93. Merck's E10 for the quarter that ended in Mar. 2025 was $3.80. Merck's Shiller PE Ratio of today is 21.30.

During the past 13 years, the highest Shiller PE Ratio of Merck was 39.37. The lowest was 19.66. And the median was 28.09.


Merck E10 Historical Data

The historical data trend for Merck's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck E10 Chart

Merck Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.49 2.94 3.43 3.37 3.59

Merck Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.54 3.68 3.78 3.59 3.80

Competitive Comparison of Merck's E10

For the Drug Manufacturers - General subindustry, Merck's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merck's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Merck's Shiller PE Ratio falls into.


;
;

Merck E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Merck's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=2.01/134.9266*134.9266
=2.010

Current CPI (Mar. 2025) = 134.9266.

Merck Quarterly Data

per share eps CPI Adj_EPS
201506 0.240 100.684 0.322
201509 0.640 100.392 0.860
201512 0.350 99.792 0.473
201603 0.400 100.470 0.537
201606 0.430 101.688 0.571
201609 0.780 101.861 1.033
201612 0.420 101.863 0.556
201703 0.560 102.862 0.735
201706 0.710 103.349 0.927
201709 -0.020 104.136 -0.026
201712 -0.323 104.011 -0.419
201803 0.270 105.290 0.346
201806 0.630 106.317 0.800
201809 0.730 106.507 0.925
201812 0.690 105.998 0.878
201903 1.120 107.251 1.409
201906 1.030 108.070 1.286
201909 0.740 108.329 0.922
201912 0.920 108.420 1.145
202003 1.260 108.902 1.561
202006 1.180 108.767 1.464
202009 1.160 109.815 1.425
202012 -0.830 109.897 -1.019
202103 1.250 111.754 1.509
202106 0.610 114.631 0.718
202109 1.800 115.734 2.098
202112 1.480 117.630 1.698
202203 1.700 121.301 1.891
202206 1.550 125.017 1.673
202209 1.280 125.227 1.379
202212 1.180 125.222 1.271
202303 1.110 127.348 1.176
202306 -2.350 128.729 -2.463
202309 1.860 129.860 1.933
202312 -0.480 129.419 -0.500
202403 1.870 131.776 1.915
202406 2.140 132.554 2.178
202409 1.240 133.029 1.258
202412 1.480 133.157 1.500
202503 2.010 134.927 2.010

Add all the adjusted EPS together and divide 10 will get our e10.


Merck  (NYSE:MRK) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Merck's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=80.93/3.80
=21.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Merck was 39.37. The lowest was 19.66. And the median was 28.09.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Merck E10 Related Terms

Thank you for viewing the detailed overview of Merck's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Merck Business Description

Address
126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
Executives
Johannes Jacobus Oosthuizen officer: SVP, U.S. Market 2000 GALLOPING HILL RD, KENILWORTH NJ 07033
David Michael Williams officer: EVP,Chief Info&Digital Officer MERCK & CO., INC., 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Inge G Thulin director 1250 5TH AVENUE SOUTH, NAPLES FL 34102
Cristal N Downing officer: Chief Comm. & Public Afrs Ofcr 2000 GALLOPING HILL RD, KENILWORTH NJ 07033
Baker Douglas M Jr director 370 WBASHA ST NORTH, ST PAUL MN 55102
Robert M Davis officer: Evp, Global Svcs & CFO 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Caroline Litchfield officer: EVP & CFO 2000 GALLOPING HILL RD, KENILWORTH NJ 07033
Joseph Romanelli officer: President, Human Health Int?l 126 EAST LINCOLN AVENUE, RAHWAY NJ 07065
Dean Y Li officer: Executive VP & President, MRL 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Richard R. Deluca officer: EVP&Pres, Merck Animal Heallth 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Steven Mizell officer: EVP,Human Resources 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Rita A Karachun officer: Sr. VP Fince-Global Controller 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Jennifer Zachary officer: EVP, General Counsel 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Sanat Chattopadhyay officer: Exe V-P & Pres. MMD 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Kenneth C Frazier officer: Chairman, President & CEO 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033